Farmaceutica REMEDIA S.A. has a high capacity to generate cash, 12.3 million lei cash and a ratio of 41.2% between liquidity and capitalization, writes Zf in 4/06/2013 edition. The dividends for 2012 reach 2.1 million lei.
A company that has more cash may perform investment that will see long-term results or distribute dividends that increase the attractiveness of short-term actions. Such a company can better withstand shocks in the financial markets.
Farmaceutica REMEDIA, in partnership with BD Rowa and Touch Point Medical, organized on 7 November 2023 the event ” Digitalized Medication Management – Improving Patient
Farmaceutica REMEDIA organized on 3 October 2023, in partnership with BD Rowa*, TouchPoint Medical, Diamedix and the Faculty of Pharmacy the event “DIGITALIZATION and MEDICATION
REMEDIA organised the seventh edition of the “Business at its home” event, dedicated to getting to know the company, after a break of 3 years.
13.02.2023 Financial Supervisory Authority Decision no 122/08.02.2023 (TRANSLATION) Name and registered office of the company concerned: The issuer / the targeted company
